KLK3 and posterior cortical atrophy: Thus, useful markers as adjuncts to serum PSA levels are needed to avoid unnecessary biopsies or over-treatment while better predicting CSPCa prior to a TRUS-Bx, which currently is the standard modality for diagnosing PCa.